R

Red Osmo | Oncologico Potosino

Research site

(Unclaimed)

Location

La Mora 139 Fraccionamiento del Parque, San Luis Potosi, San Luis Potosi, Mexico

Site insights

Top conditions

Top treatments

Tisotumab

Gemcitabine

TAR-200

Cisplatin

Pembrolizumab

Parent organization

This site is a part of Red Osmo

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2)

The purpose of study is to compare bladder intact-event free survival (BI-EFS) in participants receiving TAR-200 in combination with intravenous (IV)...

Active, not recruiting

Urinary Bladder Neoplasms

Drug: Cisplatin

Radiation: Hypo-fractioned radiation therapy

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer (ARC-10)

This is a phase 2 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) in front-line, PD-L1-high, locally advanced or metastatic...

Active, not recruiting

Squamous Non Small Cell Lung Cancer

Nonsquamous Non Small Cell Lung Cancer

Drug: Pembrolizumab

Drug: Pemetrexed

Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)

This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cer...

Active, not recruiting

Cervical Cancer

Drug: tisotumab vedotin

Drug: topotecan

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms